We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+12.37%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$11.2B
AUM Growth
+$4.26B
Cap. Flow
+$3.84B
Cap. Flow %
34.3%
Top 10 Hldgs %
50.61%
Holding
1,169
New
360
Increased
131
Reduced
115
Closed
294

Sector Composition

Rank Sector Weight
1 Technology 17.31%
2 Healthcare 16.38%
3 Financials 13.99%
4 Communication Services 7.66%
5 Consumer Discretionary 6.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MXIM
1
DELISTED
Maxim Integrated Products
MXIM
$850M 7.58%
8,064,116
+5,361,951
+198% +$525M
ALXN
2
DELISTED
Alexion Pharmaceuticals
ALXN
$813M 7.26%
4,428,122
+2,861,349
+183% +$491M
INFO
3
DELISTED
IHS Markit Ltd. Common Shares
INFO
$659M 5.88%
5,846,058
+375,881
+7% +$39.9M
PPD
4
DELISTED
PPD, Inc. Common Stock
PPD
$658M 5.87%
+14,271,048
New +$645M
NUAN
5
DELISTED
Nuance Communications, Inc.
NUAN
$557M 4.97%
+10,225,428
New +$539M
VER
6
DELISTED
VEREIT, Inc.
VER
$529M 4.72%
11,517,150
+11,498,250
+60,837% +$520M
WORK
7
DELISTED
Slack Technologies, Inc.
WORK
$491M 4.38%
11,073,242
+642,990
+6% +$27.5M
GRA
8
DELISTED
W.R. Grace & Co.
GRA
$404M 3.61%
+5,845,554
New +$394M
KSU
9
DELISTED
Kansas City Southern
KSU
$356M 3.18%
1,258,013
+608,013
+94% +$176M
QTS
10
DELISTED
QTS REALTY TRUST, INC.
QTS
$355M 3.17%
+4,589,086
New +$312M
PFPT
11
DELISTED
Proofpoint, Inc.
PFPT
$299M 2.67%
+1,719,764
New +$279M
PRAH
12
DELISTED
PRA Health Sciences, Inc.
PRAH
$294M 2.63%
1,781,846
+1,531,846
+613% +$256M
ATH
13
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$272M 2.43%
4,035,238
+3,535,238
+707% +$213M
XLNX
14
DELISTED
Xilinx Inc
XLNX
$201M 1.79%
1,389,352
+81,668
+6% +$10.4M
TLND
15
DELISTED
Talend S.A. American Depositary Shares
TLND
$184M 1.64%
+2,807,976
New +$182M
CIT
16
DELISTED
CIT Group Inc.
CIT
$139M 1.24%
2,703,670
+1,998,890
+284% +$105M
CHNG
17
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$102M 0.91%
4,413,561
+1,516,900
+52% +$34.9M
NAV
18
DELISTED
Navistar International
NAV
$90.3M 0.81%
2,030,345
+116,422
+6% +$5.16M
COHR
19
DELISTED
Coherent Inc
COHR
$86.1M 0.77%
+325,553
New +$85.6M
PBCT
20
DELISTED
People's United Financial Inc
PBCT
$84.6M 0.75%
4,934,837
+4,889,573
+10,802% +$89.3M
BBL
21
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$82.2M 0.73%
1,377,354
+84,125
+7% +$5.14M
HRTX icon
22
Heron Therapeutics
HRTX
$94.5M
$68.7M 0.61%
4,425,000
+2,100,000
+90% +$33.4M
CBB
23
DELISTED
Cincinnati Bell Inc.
CBB
$63M 0.56%
4,083,178
+2,160,807
+112% +$33.3M
WRI
24
DELISTED
Weingarten Realty Investors
WRI
$50.2M 0.45%
+1,565,649
New +$49.3M
MGLN
25
DELISTED
Magellan Health Services, Inc.
MGLN
$35.4M 0.32%
376,242
+89,571
+31% +$8.44M

Similar funds

UBS O'Connor's Q2 2021 Portfolio in Review

As of Q2 2021, UBS O'Connor held 1,169 positions worth $11.2B, up 61% from $6.94B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

UBS O'Connor deployed $3.84B of net new capital in Q2 2021, opening 360 new positions and adding to 131 existing holdings. Its largest new stake was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was MasTec, an estimated $7.65M trimmed.

  • UBS O'Connor's largest Q2 2021 buy was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.
  • UBS O'Connor added most to Maxim Integrated Products in Q2 2021, an estimated $525M increase.
  • UBS O'Connor's biggest Q2 2021 reduction was MasTec, cutting an estimated $7.65M.
  • UBS O'Connor fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $475M.
  • UBS O'Connor's ten largest holdings make up 51% of its $11.2B portfolio in Q2 2021.
  • UBS O'Connor opened 360 new positions and closed 294 in Q2 2021.
  • UBS O'Connor's portfolio value rose 61% quarter-over-quarter to $11.2B.

Based on UBS O'Connor's 13F filing for Q2 2021, filed 13 Aug 2021.